Grotzinger KM - Search Results

1

Cost-Effectiveness of Eltrombopag versus Romiplostim for the Treatment of Chronic Immune Thrombocytopenia in England and Wales.

Allen R, Bryden P, Grotzinger KM, Stapelkamp C, Woods B. Allen R, et al. Among authors: grotzinger km. Value Health. 2016 Jul-Aug;19(5):614-22. doi: 10.1016/j.jval.2016.03.1856. Epub 2016 May 11. Value Health. 2016. PMID: 27565278 Free article.

2

A comment on Boyers et al.: "eltrombopag for the treatment of chronic immune or idiopathic thrombocytopenic purpura: a NICE single technology appraisal".

Allen R, Brainsky A, Grotzinger K, Roccia T. Allen R, et al. Pharmacoeconomics. 2013 Jan;31(1):87-9. doi: 10.1007/s40273-012-0003-8. Pharmacoeconomics. 2013. PMID: 23329595 Free PMC article. No abstract available.

3

Grotzinger KM, Younossi ZM, Giannini EG, Chen PJ, Rendas-Baum R, Theodore D. Grotzinger KM, et al. Health Qual Life Outcomes. 2016 Mar 22;14:49. doi: 10.1186/s12955-016-0447-1. Health Qual Life Outcomes. 2016. PMID: 27004952 Free PMC article.

4

Grainger JD, Blanchette VS, Grotzinger KM, Roy A, Bussel JB. Grainger JD, et al. Among authors: grotzinger km. Br J Haematol. 2019 Apr;185(1):102-106. doi: 10.1111/bjh.15732. Epub 2018 Dec 27. Br J Haematol. 2019. PMID: 30592022 Free article.

5

Changes in health-related quality of life with long-term eltrombopag treatment in adults with persistent/chronic immune thrombocytopenia: Findings from the EXTEND study.

Khelif A, Saleh MN, Salama A, Portella MDSO, Duh MS, Ivanova J, Grotzinger K, Roy AN, Bussel JB. Khelif A, et al. Am J Hematol. 2019 Feb;94(2):200-208. doi: 10.1002/ajh.25348. Epub 2018 Nov 29. Am J Hematol. 2019. PMID: 30417939 Free PMC article.

6

Treatment patterns and clinical outcomes in patients with chronic immune thrombocytopenia (ITP) switched to eltrombopag or romiplostim.

Kuter DJ, Macahilig C, Grotzinger KM, Poston SA, Wang PF, Dawson KL, Ward M. Kuter DJ, et al. Among authors: grotzinger km. Int J Hematol. 2015 Mar;101(3):255-63. doi: 10.1007/s12185-014-1731-7. Epub 2015 Jan 14. Int J Hematol. 2015. PMID: 25586660

7

Patient-reported treatment burden of chronic immune thrombocytopenia therapies.

Brown TM, Horblyuk RV, Grotzinger KM, Matzdorff AC, Pashos CL. Brown TM, et al. Among authors: grotzinger km. BMC Blood Disord. 2012 Mar 22;12:2. doi: 10.1186/1471-2326-12-2. BMC Blood Disord. 2012. PMID: 22436142 Free PMC article.

8

Validation of the FACIT-fatigue subscale, selected items from FACT-thrombocytopenia, and the SF-36v2 in patients with chronic immune thrombocytopenia.

Signorovitch J, Brainsky A, Grotzinger KM. Signorovitch J, et al. Among authors: grotzinger km. Qual Life Res. 2011 Dec;20(10):1737-44. doi: 10.1007/s11136-011-9912-9. Epub 2011 May 1. Qual Life Res. 2011. PMID: 21533818 Clinical Trial.

9

A methodology for successfully producing global translations of patient reported outcome measures for use in multiple countries.

Two R, Verjee-Lorenz A, Clayson D, Dalal M, Grotzinger K, Younossi ZM. Two R, et al. Value Health. 2010 Jan-Feb;13(1):128-31. doi: 10.1111/j.1524-4733.2009.00585.x. Epub 2009 Aug 20. Value Health. 2010. PMID: 19695006 Free article.

10

Selective validation of the WHO Bleeding Scale in patients with chronic immune thrombocytopenia.

Fogarty PF, Tarantino MD, Brainsky A, Signorovitch J, Grotzinger KM. Fogarty PF, et al. Among authors: grotzinger km. Curr Med Res Opin. 2012 Jan;28(1):79-87. doi: 10.1185/03007995.2011.644849. Epub 2011 Dec 20. Curr Med Res Opin. 2012. PMID: 22117897

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

26 results

Search Page

Filters